BMC Bioinformatics · 2006 · 43 citations · 10 references
MedicineBiostatisticsOncologyEarly DetectionMass Spectrometric AnalysisProteomicsBiomarker DiscoveryCancer BiomarkersMass SpectrometryMass Spectrometry Data AnalysisMass Spectrometry-based ProteomicsProteomic BiomarkersData Analysis AlgorithmsMass Spectral Data AnalysisMass Spectrometry ProteomicsProteomic Biomarker DiscoveryProteomic Data AnalysisTumor Biomarker Discovery
BACKGROUND: Proteomic data obtained from mass spectrometry have attracted great interest for the detection of early-stage cancer. However, as mass spectrometry data are high-dimensional, identification of biomarkers is a key problem. RESULTS: This paper proposes the use of "common" peaks in data as biomarkers. Analysis is conducted as follows: data preprocessing, identification of biomarkers, and application of AdaBoost to construct a classification function. Informative "common" peaks are selected by AdaBoost. AsymBoost is also examined to balance false negatives and false positives. The effectiveness of the approach is demonstrated using an ovarian cancer dataset. CONCLUSION: Continuous covariates and discrete covariates can be used in the present approach. The difference between the result for the continuous covariates and that for the discrete covariates was investigated in detail. In the example considered here, both covariates provide a good prediction, but it seems that they provide different kinds of information. We can obtain more information on the structure of the data by integrating both results.
10
Use of proteomic patterns in serum to identify ovarian cancer
Emanuel F. Petricoin, Ali M. Ardekani, Ben A. Hitt et al. · The Lancet · 2002 · 3.3K citations
Medicine, Gynecology, Oncology +17
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data
Baolin Wu, Tom Abbott, David A. Fishman et al. · Bioinformatics · 2003 · 485 citations · Full text
Medicine, Bioinformatics, Oncology +17